03:36 PM EDT, 09/19/2025 (MT Newswires) -- Health care stocks were mixed late Friday afternoon with the NYSE Health Care Index easing 0.1% and the Health Care Select Sector SPDR Fund (XLV) up 0.1%.

The iShares Biotechnology ETF (IBB) declined 0.5%.

In corporate news, Johnson & Johnson ( JNJ ) said an experimental immune-based induction treatment combining Tecvayli and Darzalex Faspro showed "meaningful" efficacy in some multiple myeloma patients. The shares rose 1.2%.